NEW YORK (GenomeWeb News) – Accelrys yesterday reported a 1 percent decline in revenues for its first fiscal quarter as its net income improved over the year-ago period.

Accelrys said that revenues for the three months ended June 30 decreased to $20.1 million from $20.3 million in the prior-year period. The company attributed the decrease to a drop in maintenance revenue of around $400,000, which was partially offset by an increase in software revenue of around $300,000.

Net income increased to $744,000 from $86,000 in the comparable period of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.